Siyora Pharmaceuticals Private Limited
About Siyora Pharmaceuticals Private Limited
Data last updated:
Siyora Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2019PTC323362. Its GSTIN is 36ABBCS8371F1Z6 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manchala Srinivasulu and Ramu Vemulakonda.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B/208 Mangalmurti Biulding Goregaon Subh Ngr Chs Sanskardham Collegegoregaonb/20, Mumbai, Maharashtra, India – 400090.
As per the financials filed for FY 2023, the company reported a revenue of ₹35.31 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹3,634 (net margin 0.1%) and EBITDA of ₹25,498 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Company details
Contact details
Siyora Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB/208 Mangalmurti Biulding Goregaon Subh Ngr Chs Sanskardham Collegegoregaonb/20, Mumbai, Maharashtra, India – 400090
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Siyora Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Siyora Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Siyora Pharmaceuticals Private Limited, buy the company report.
Financials of Siyora Pharmaceuticals Private Limited
FY 2023 filings availableSiyora Pharmaceuticals Private Limited reported revenue of ₹35.31 Lakh (up 16% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 16% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,498 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,634 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Siyora Pharmaceuticals Private Limited, buy the company report.
Board of directors of Siyora Pharmaceuticals Private Limited
Siyora Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manchala Srinivasulu | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
| Ramu Vemulakonda | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
Peer comparison
Siyora Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tuffail (India) Pharmaceuticals Private Limited | ₹35.61 Lakh (FY 2025) | -14.0% | Gorakhpur, Uttar Pradesh, India | |||
| Agena Pharmaceuticals Private Limited | ₹35.6 Lakh (FY 2023) | 102.0% | Kushinagar, Uttar Pradesh, India | |||
| Siyora Pharmaceuticals Private Limitedthis company | ₹35.31 Lakh (FY 2023) | ₹3,634 | 0.1% | 16.0% | Mumbai, Maharashtra, India | |
| Ubnap Pharmaceuticals Private Limited | ₹35.24 Lakh (FY 2025) | 79.0% | Lucknow, Uttar Pradesh, India | |||
| Npvet Pharmaceuticals Private Limited | ₹35.02 Lakh (FY 2025) | 29.0% | Jhansi, Uttar Pradesh, India | |||
| Peregrine Falcon Pharmaceuticals Private Limited | ₹34.9 Lakh (FY 2025) | -10.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Siyora Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Siyora Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siyora Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Siyora Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS8371F1Z6 | Telangana | Active | 12 Apr 2019 |
To see the full GST registrations and return filing status of Siyora Pharmaceuticals Private Limited, buy the company report.
Recent activity
Siyora Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Manchala Srinivasulu was appointed as Director on 29 Mar 2019.
Frequently asked questions
Siyora Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 March 2019 (7+ years old) and is registered under CIN U24239MH2019PTC323362.
Siyora Pharmaceuticals has 2 current directors:
- Manchala Srinivasulu - Director
- Ramu Vemulakonda - Director
The latest financial statements of Siyora Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Siyora Pharmaceuticals is 36ABBCS8371F1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Siyora Pharmaceuticals is U24239MH2019PTC323362. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siyora Pharmaceuticals was incorporated on 29 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Siyora Pharmaceuticals by revenue are Tuffail (India) Pharmaceuticals Private Limited, Agena Pharmaceuticals Private Limited, Ubnap Pharmaceuticals Private Limited, Npvet Pharmaceuticals Private Limited, Peregrine Falcon Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manchala Srinivasulu was appointed as Director on 29 Mar 2019. Ramu Vemulakonda was appointed as Director on 29 Mar 2019.
The registered office of Siyora Pharmaceuticals is at B208 Mangalmurti Biulding Goregaon Subh Ngr Chs Sanskardham Collegegoregaonb20, Mumbai, Maharashtra, India – 400090.
Siyora Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Siyora Pharmaceuticals can be reached at its registered office: B208 Mangalmurti Biulding Goregaon Subh Ngr Chs Sanskardham Collegegoregaonb20, Mumbai, Maharashtra, India – 400090.